Trial intelligence / Profile preview

Immunogenicity of MR and JE Vaccine Co-administration in Infants

NCT02643433Phase 4Completed

Sponsor
Centers for Disease Control and Prevention
Start
Aug 2015
Primary completion
Jun 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of japanese encephalitis vaccine sa14-14-2 in Japanese encephalitis (JE), sponsored by Centers for Disease Control and Prevention. Started Aug 2015; status: completed.

02

Drugs

japanese encephalitis vaccine sa14-14-2
03

Conditions

Japanese encephalitis (JE)

Beyond the preview

Go deeper on NCT02643433.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02643433.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call